Home > > > Report Detail

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Publisher Name :
Date: 10-Jan-2024
No. of pages: 93
Inquire Before Buying

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and The rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, The industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in The market and ensure their products reach patients in need. Additionally, The COVID-19 pandemic has highlighted The importance of vaccine development and supply chain management, further emphasizing The need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of The global market for Sleeping Pills (Prescription Drugs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess The market competitive situation, analyze their position in The current marketplace, and make informed business decisions regarding Sleeping Pills (Prescription Drugs).

Report Scope

The Sleeping Pills (Prescription Drugs) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as The base year, with history and forecast data for The period from 2019 to 2030. This report segments The global Sleeping Pills (Prescription Drugs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of The market, The report provides profiles of The competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help The Sleeping Pills (Prescription Drugs) manufacturers, new entrants, and industry chain related companies in this market with information on The revenues, sales volume, and average price for The overall market and The sub-segments across The different segments, By Company, by Type, by Application, and By Regions.

Market Segmentation

By Company

- Sanofi

- Abbott Laboratories

- Takeda Pharmaceutical

- Apotex

- Aurobindo Pharma

- Actellon Pharmaceuticals

- Allegiant Health

- Cayman Chemical

- Ambitropin

- Hayao

Segment by Type

- Zolpidem

- Eszopiclone (Lunesta)

- Ramelteon (Rozerem)

- Ativan (lorazepam)

- Adapin (doxepin)

Segment by Application

- Hospital Pharmacy

- Retail Pharmacy

Consumption By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Chapter Outline

Chapter 1: Introduces The Report Scope of The report, executive summary of different market segments (

By Region, by Type, by Application, etc), including The market size of each market segment, future development potential, and so on. It offers a high-level view of The current state of The market and its likely evolution in The short to mid-term, and long term.

Chapter 2: Detailed analysis of Sleeping Pills (Prescription Drugs) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Sleeping Pills (Prescription Drugs) in regional level and country level. It provides a quantitative analysis of The market size and development potential of each region and its main countries and introduces The market development, future development prospects, market space, and market size of each country in The world.

Chapter 4: Provides The analysis of various market segments by Type, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different market segments.

Chapter 5: Provides The analysis of various market segments by Application, covering The market size and development potential of each market segment, to help readers find The blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing The basic situation of The main companies in The market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including The upstream and downstream of The industry.

Chapter 8: Introduces The market dynamics, latest developments of The market, The driving factors and restrictive factors of The market, The challenges and risks faced by manufacturers in The industry, and The analysis of relevant policies in The industry.

Chapter 9: The main points and conclusions of The report.

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Table of Contents
1 Sleeping Pills (Prescription Drugs) Market Overview
1.1 Product Overview and Scope of Sleeping Pills (Prescription Drugs)
1.2 Sleeping Pills (Prescription Drugs) Segment by Type
1.2.1 Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2024-2030)
1.2.2 Zolpidem
1.2.3 Eszopiclone (Lunesta)
1.2.4 Ramelteon (Rozerem)
1.2.5 Ativan (lorazepam)
1.2.6 Adapin (doxepin)
1.3 Sleeping Pills (Prescription Drugs) Segment by Application
1.3.1 Global Sleeping Pills (Prescription Drugs) Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.4 Global Sleeping Pills (Prescription Drugs) Market Size Estimates and Forecasts
1.4.1 Global Sleeping Pills (Prescription Drugs) Revenue 2019-2030
1.4.2 Global Sleeping Pills (Prescription Drugs) Sales 2019-2030
1.4.3 Global Sleeping Pills (Prescription Drugs) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Sleeping Pills (Prescription Drugs) Market Competition by Manufacturers
2.1 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Sleeping Pills (Prescription Drugs) Average Price by Manufacturers (2019-2024)
2.4 Global Sleeping Pills (Prescription Drugs) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Product Type & Application
2.7 Sleeping Pills (Prescription Drugs) Market Competitive Situation and Trends
2.7.1 Sleeping Pills (Prescription Drugs) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sleeping Pills (Prescription Drugs) Players Market Share by Revenue
2.7.3 Global Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sleeping Pills (Prescription Drugs) Retrospective Market Scenario by Region
3.1 Global Sleeping Pills (Prescription Drugs) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Sleeping Pills (Prescription Drugs) Global Sleeping Pills (Prescription Drugs) Sales by Region: 2019-2030
3.2.1 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2019-2024
3.2.2 Global Sleeping Pills (Prescription Drugs) Sales by Region: 2025-2030
3.3 Global Sleeping Pills (Prescription Drugs) Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2019-2030
3.3.1 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2019-2024
3.3.2 Global Sleeping Pills (Prescription Drugs) Revenue by Region: 2025-2030
3.4 North America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.4.1 North America Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.4.3 North America Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.5.1 Europe Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.5.3 Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.6.1 Asia Pacific Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.6.3 Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.7.1 Latin America Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.7.3 Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Facts & Figures by Country
3.8.1 Middle East and Africa Sleeping Pills (Prescription Drugs) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Sleeping Pills (Prescription Drugs) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2019-2030)
4.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Type (2019-2024)
4.1.2 Global Sleeping Pills (Prescription Drugs) Sales by Type (2025-2030)
4.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2019-2030)
4.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2019-2030)
4.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2019-2024)
4.2.2 Global Sleeping Pills (Prescription Drugs) Revenue by Type (2025-2030)
4.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2019-2030)
4.3 Global Sleeping Pills (Prescription Drugs) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2019-2030)
5.1.1 Global Sleeping Pills (Prescription Drugs) Sales by Application (2019-2024)
5.1.2 Global Sleeping Pills (Prescription Drugs) Sales by Application (2025-2030)
5.1.3 Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2019-2030)
5.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2019-2030)
5.2.1 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2019-2024)
5.2.2 Global Sleeping Pills (Prescription Drugs) Revenue by Application (2025-2030)
5.2.3 Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2019-2030)
5.3 Global Sleeping Pills (Prescription Drugs) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Sleeping Pills (Prescription Drugs) Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbott Laboratories Sleeping Pills (Prescription Drugs) Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Takeda Pharmaceutical
6.3.1 Takeda Pharmaceutical Corporation Information
6.3.2 Takeda Pharmaceutical Description and Business Overview
6.3.3 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product Portfolio
6.3.5 Takeda Pharmaceutical Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Sleeping Pills (Prescription Drugs) Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Aurobindo Pharma
6.5.1 Aurobindo Pharma Corporation Information
6.5.2 Aurobindo Pharma Description and Business Overview
6.5.3 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product Portfolio
6.5.5 Aurobindo Pharma Recent Developments/Updates
6.6 Actellon Pharmaceuticals
6.6.1 Actellon Pharmaceuticals Corporation Information
6.6.2 Actellon Pharmaceuticals Description and Business Overview
6.6.3 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product Portfolio
6.6.5 Actellon Pharmaceuticals Recent Developments/Updates
6.7 Allegiant Health
6.6.1 Allegiant Health Corporation Information
6.6.2 Allegiant Health Description and Business Overview
6.6.3 Allegiant Health Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Allegiant Health Sleeping Pills (Prescription Drugs) Product Portfolio
6.7.5 Allegiant Health Recent Developments/Updates
6.8 Cayman Chemical
6.8.1 Cayman Chemical Corporation Information
6.8.2 Cayman Chemical Description and Business Overview
6.8.3 Cayman Chemical Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cayman Chemical Sleeping Pills (Prescription Drugs) Product Portfolio
6.8.5 Cayman Chemical Recent Developments/Updates
6.9 Ambitropin
6.9.1 Ambitropin Corporation Information
6.9.2 Ambitropin Description and Business Overview
6.9.3 Ambitropin Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Ambitropin Sleeping Pills (Prescription Drugs) Product Portfolio
6.9.5 Ambitropin Recent Developments/Updates
6.10 Hayao
6.10.1 Hayao Corporation Information
6.10.2 Hayao Description and Business Overview
6.10.3 Hayao Sleeping Pills (Prescription Drugs) Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Hayao Sleeping Pills (Prescription Drugs) Product Portfolio
6.10.5 Hayao Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sleeping Pills (Prescription Drugs) Industry Chain Analysis
7.2 Sleeping Pills (Prescription Drugs) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sleeping Pills (Prescription Drugs) Production Mode & Process
7.4 Sleeping Pills (Prescription Drugs) Sales and Marketing
7.4.1 Sleeping Pills (Prescription Drugs) Sales Channels
7.4.2 Sleeping Pills (Prescription Drugs) Distributors
7.5 Sleeping Pills (Prescription Drugs) Customers
8 Sleeping Pills (Prescription Drugs) Market Dynamics
8.1 Sleeping Pills (Prescription Drugs) Industry Trends
8.2 Sleeping Pills (Prescription Drugs) Market Drivers
8.3 Sleeping Pills (Prescription Drugs) Market Challenges
8.4 Sleeping Pills (Prescription Drugs) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Sleeping Pills (Prescription Drugs) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Sleeping Pills (Prescription Drugs) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Sleeping Pills (Prescription Drugs) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Sleeping Pills (Prescription Drugs), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Product Type & Application
Table 12. Global Key Manufacturers of Sleeping Pills (Prescription Drugs), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Sleeping Pills (Prescription Drugs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sleeping Pills (Prescription Drugs) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Sleeping Pills (Prescription Drugs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Sleeping Pills (Prescription Drugs) Sales by Region (2019-2024) & (K Units)
Table 18. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2019-2024)
Table 19. Global Sleeping Pills (Prescription Drugs) Sales by Region (2025-2030) & (K Units)
Table 20. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2025-2030)
Table 21. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2019-2024)
Table 23. Global Sleeping Pills (Prescription Drugs) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2025-2030)
Table 25. North America Sleeping Pills (Prescription Drugs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Sleeping Pills (Prescription Drugs) Sales by Country (2019-2024) & (K Units)
Table 27. North America Sleeping Pills (Prescription Drugs) Sales by Country (2025-2030) & (K Units)
Table 28. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Sleeping Pills (Prescription Drugs) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Sleeping Pills (Prescription Drugs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Sleeping Pills (Prescription Drugs) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Sleeping Pills (Prescription Drugs) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Sleeping Pills (Prescription Drugs) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Sleeping Pills (Prescription Drugs) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Sleeping Pills (Prescription Drugs) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2019-2024)
Table 51. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Type (2025-2030)
Table 52. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2019-2024)
Table 53. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Type (2025-2030)
Table 54. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2019-2024)
Table 57. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Type (2025-2030)
Table 58. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Type (2019-2024)
Table 59. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Type (2025-2030)
Table 60. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Application (2019-2024)
Table 61. Global Sleeping Pills (Prescription Drugs) Sales (K Units) by Application (2025-2030)
Table 62. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2019-2024)
Table 63. Global Sleeping Pills (Prescription Drugs) Sales Market Share by Application (2025-2030)
Table 64. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Sleeping Pills (Prescription Drugs) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2019-2024)
Table 67. Global Sleeping Pills (Prescription Drugs) Revenue Market Share by Application (2025-2030)
Table 68. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Application (2019-2024)
Table 69. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Application (2025-2030)
Table 70. Sanofi Corporation Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Sanofi Sleeping Pills (Prescription Drugs) Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Abbott Laboratories Corporation Information
Table 76. Abbott Laboratories Description and Business Overview
Table 77. Abbott Laboratories Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Abbott Laboratories Sleeping Pills (Prescription Drugs) Product
Table 79. Abbott Laboratories Recent Developments/Updates
Table 80. Takeda Pharmaceutical Corporation Information
Table 81. Takeda Pharmaceutical Description and Business Overview
Table 82. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Takeda Pharmaceutical Sleeping Pills (Prescription Drugs) Product
Table 84. Takeda Pharmaceutical Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Sleeping Pills (Prescription Drugs) Product
Table 89. Apotex Recent Developments/Updates
Table 90. Aurobindo Pharma Corporation Information
Table 91. Aurobindo Pharma Description and Business Overview
Table 92. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Aurobindo Pharma Sleeping Pills (Prescription Drugs) Product
Table 94. Aurobindo Pharma Recent Developments/Updates
Table 95. Actellon Pharmaceuticals Corporation Information
Table 96. Actellon Pharmaceuticals Description and Business Overview
Table 97. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Actellon Pharmaceuticals Sleeping Pills (Prescription Drugs) Product
Table 99. Actellon Pharmaceuticals Recent Developments/Updates
Table 100. Allegiant Health Corporation Information
Table 101. Allegiant Health Description and Business Overview
Table 102. Allegiant Health Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Allegiant Health Sleeping Pills (Prescription Drugs) Product
Table 104. Allegiant Health Recent Developments/Updates
Table 105. Cayman Chemical Corporation Information
Table 106. Cayman Chemical Description and Business Overview
Table 107. Cayman Chemical Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Cayman Chemical Sleeping Pills (Prescription Drugs) Product
Table 109. Cayman Chemical Recent Developments/Updates
Table 110. Ambitropin Corporation Information
Table 111. Ambitropin Description and Business Overview
Table 112. Ambitropin Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Ambitropin Sleeping Pills (Prescription Drugs) Product
Table 114. Ambitropin Recent Developments/Updates
Table 115. Hayao Corporation Information
Table 116. Hayao Description and Business Overview
Table 117. Hayao Sleeping Pills (Prescription Drugs) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Hayao Sleeping Pills (Prescription Drugs) Product
Table 119. Hayao Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Sleeping Pills (Prescription Drugs) Distributors List
Table 123. Sleeping Pills (Prescription Drugs) Customers List
Table 124. Sleeping Pills (Prescription Drugs) Market Trends
Table 125. Sleeping Pills (Prescription Drugs) Market Drivers
Table 126. Sleeping Pills (Prescription Drugs) Market Challenges
Table 127. Sleeping Pills (Prescription Drugs) Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Sleeping Pills (Prescription Drugs)
Figure 2. Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Sleeping Pills (Prescription Drugs) Market Share by Type in 2023 & 2030
Figure 4. Zolpidem Product Picture
Figure 5. Eszopiclone (Lunesta) Product Picture
Figure 6. Ramelteon (Rozerem) Product Picture
Figure 7. Ativan (lorazepam) Product Picture
Figure 8. Adapin (doxepin) Product Picture
Figure 9. Global Sleeping Pills (Prescription Drugs) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Sleeping Pills (Prescription Drugs) Market Share by Application in 2023 & 2030
Figure 11. Hospital Pharmacy
Figure 12. Retail Pharmacy
Figure 13. Global Sleeping Pills (Prescription Drugs) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Sleeping Pills (Prescription Drugs) Market Size (2019-2030) & (US$ Million)
Figure 15. Global Sleeping Pills (Prescription Drugs) Sales (2019-2030) & (K Units)
Figure 16. Global Sleeping Pills (Prescription Drugs) Average Price (USD/Unit) & (2019-2030)
Figure 17. Sleeping Pills (Prescription Drugs) Report Years Considered
Figure 18. Sleeping Pills (Prescription Drugs) Sales Share by Manufacturers in 2023
Figure 19. Global Sleeping Pills (Prescription Drugs) Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Sleeping Pills (Prescription Drugs) Players: Market Share by Revenue in 2023
Figure 21. Sleeping Pills (Prescription Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Sleeping Pills (Prescription Drugs) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2019-2030)
Figure 24. North America Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2019-2030)
Figure 28. Europe Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2019-2030)
Figure 29. Germany Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Sleeping Pills (Prescription Drugs) Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Sleeping Pills (Prescription Drugs) Revenue Market Share by Region (2019-2030)
Figure 36. China Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2019-2030)
Figure 47. Latin America Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Sleeping Pills (Prescription Drugs) Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Sleeping Pills (Prescription Drugs) Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Sleeping Pills (Prescription Drugs) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Sleeping Pills (Prescription Drugs) by Type (2019-2030)
Figure 57. Global Revenue Market Share of Sleeping Pills (Prescription Drugs) by Type (2019-2030)
Figure 58. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Type (2019-2030)
Figure 59. Global Sales Market Share of Sleeping Pills (Prescription Drugs) by Application (2019-2030)
Figure 60. Global Revenue Market Share of Sleeping Pills (Prescription Drugs) by Application (2019-2030)
Figure 61. Global Sleeping Pills (Prescription Drugs) Price (USD/Unit) by Application (2019-2030)
Figure 62. Sleeping Pills (Prescription Drugs) Value Chain
Figure 63. Sleeping Pills (Prescription Drugs) Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs